NFL Biosciences SA (ALNFL.PA)
EUR 1.38
(2.22%)
EUR 1.38
(2.22%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -56.06 Thousand EUR | 97.49% |
| 2022 | -2.23 Million EUR | -321.25% |
| 2021 | -530.73 Thousand EUR | -213.38% |
| 2020 | -169.35 Thousand EUR | 33.29% |
| 2019 | -253.87 Thousand EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -25.91 Thousand EUR | 5.1% |
| 2023 FY | -56.06 Thousand EUR | 97.49% |
| 2023 Q4 | -27.3 Thousand EUR | 5.04% |
| 2023 Q2 | -28.75 Thousand EUR | -7.67% |
| 2022 Q4 | -26.7 Thousand EUR | -3.78% |
| 2022 FY | -2.23 Million EUR | -321.25% |
| 2022 Q2 | -25.73 Thousand EUR | 0.0% |
| 2021 FY | -530.73 Thousand EUR | -213.38% |
| 2021 Q2 | -20.58 Thousand EUR | 0.0% |
| 2020 FY | -169.35 Thousand EUR | 33.29% |
| 2019 FY | -253.87 Thousand EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| ABIONYX Pharma SA | 618 Thousand EUR | 109.072% |
| ABIVAX Société Anonyme | 3.91 Million EUR | 101.432% |
| Adocia SA | 1.38 Million EUR | 104.048% |
| Aelis Farma SA | 12.35 Million EUR | 100.454% |
| Biophytis S.A. | -803 Thousand EUR | 93.018% |
| Advicenne S.A. | 1.42 Million EUR | 103.932% |
| genOway Société anonyme | 20.1 Million EUR | 100.279% |
| IntegraGen SA | 5.01 Million EUR | 101.117% |
| Medesis Pharma S.A. | -2.66 Million EUR | 97.896% |
| Neovacs S.A. | 29.31 Thousand EUR | 291.253% |
| Plant Advanced Technologies SA | 2.15 Million EUR | 102.604% |
| Quantum Genomics Société Anonyme | -1.41 Million EUR | 96.05% |
| Sensorion SA | 3.78 Million EUR | 101.48% |
| Theranexus Société Anonyme | -4.63 Million EUR | 98.791% |
| TME Pharma N.V. | -127 Thousand EUR | 55.855% |
| Valbiotis SA | 2.66 Million EUR | 102.101% |
| TheraVet SA | -530.79 Thousand EUR | 89.438% |
| Valerio Therapeutics Société anonyme | 1.26 Million EUR | 104.425% |
| DBV Technologies S.A. | 4.15 Million EUR | 101.348% |
| Genfit S.A. | 28.22 Million EUR | 100.199% |
| GeNeuro SA | -293.8 Thousand EUR | 80.918% |
| Innate Pharma S.A. | -4.12 Million EUR | 98.64% |
| Inventiva S.A. | 17.5 Million EUR | 100.32% |
| MaaT Pharma SA | 1.65 Million EUR | 103.388% |
| MedinCell S.A. | 9.28 Million EUR | 100.604% |
| Nanobiotix S.A. | 36.2 Million EUR | 100.155% |
| OSE Immunotherapeutics SA | 2.22 Million EUR | 102.517% |
| Poxel S.A. | 1000.00 EUR | 5706.4% |
| GenSight Biologics S.A. | 3 Million EUR | 101.869% |
| Transgene SA | -28.4 Million EUR | 99.803% |
| Valneva SE | 52.83 Million EUR | 100.106% |